Electromed, Inc., a medical device company based in New Prague, MN, has shared an investor presentation highlighting its position as a leader in airway clearance technologies. The company reported an annual revenue of $61.5 million and a market capitalization of $204 million. Electromed's SmartVest® Airway Clearance System, utilizing High Frequency Chest Wall Oscillation (HFCWO) technology, is supported by clinical outcomes data and strong reimbursement. The presentation underscores Electromed's direct-to-patient and provider model, solid financial profile, and attractive gross margins. The company emphasizes its focus on addressing bronchiectasis, a lung condition often misdiagnosed and under-prescribed for HFCWO treatment. You can access the full presentation through the link below.